Boston Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$473K Sell
6,400
-550
-8% -$39.5K 0.02% 467
2019
Q2
$541K Sell
6,950
-600
-8% -$45.6K 0.03% 467
2019
Q1
$573K Sell
7,550
-67
-0.9% -$5.33K 0.03% 445
2018
Q4
$557K Sell
7,617
-180
-2% -$14.3K 0.03% 434
2018
Q3
$746K Sell
7,797
-1,050
-12% -$104K 0.03% 424
2018
Q2
$884K Sell
8,847
-470
-5% -$49.6K 0.02% 401
2018
Q1
$984K Sell
9,317
-100
-1% -$10.1K 0.03% 368
2017
Q4
$872K Sell
9,417
-500
-5% -$45.4K 0.02% 396
2017
Q3
$897K Hold
9,917
0.02% 377
2017
Q2
$833K Buy
9,917
+17
+0.2% +$1.37K 0.02% 397
2017
Q1
$800K Sell
9,900
-11,455
-54% -$901K 0.02% 388
2016
Q4
$1.61M Buy
21,355
+293
+1% +$21.2K 0.04% 313
2016
Q3
$1.43M Sell
21,062
-188,723
-90% -$12.7M 0.04% 314
2016
Q2
$14.2M Buy
209,785
+199,435
+1,927% +$14.7M 0.36% 96
2016
Q1
$748K Sell
10,350
-1,313
-11% -$86K 0.02% 368
2015
Q4
$787K Sell
11,663
-87
-0.7% -$6.09K 0.02% 365
2015
Q3
$760K Sell
11,750
-367
-3% -$27.1K 0.03% 426
2015
Q2
$991K Sell
12,117
-849
-7% -$65.5K 0.04% 293
2015
Q1
$898K Sell
12,966
-6,605
-34% -$477K 0.04% 305
2014
Q4
$1.49M Sell
19,571
-7,970
-29% -$630K 0.06% 225
2014
Q3
$2.23M Sell
27,541
-155,643
-85% -$13M 0.09% 199
2014
Q2
$16M Buy
183,184
+2,785
+2% +$242K 0.68% 42
2014
Q1
$15.6M Sell
180,399
-1,505
-0.8% -$123K 0.69% 41
2013
Q4
$14.7M Buy
181,904
+1,060
+0.6% +$82.3K 0.7% 42
2013
Q3
$14.1M Sell
180,844
-36,608
-17% -$2.82M 0.75% 40
2013
Q2
$15.2M Buy
+217,452
New +$15.2M 0.73% 46

Other funds holding EMN

Boston Advisors's EMN Position: Q3 2019 in Review

Boston Advisors reduced its Eastman Chemical (EMN) stake by 7.9% in Q3 2019, selling an estimated $39.5K and leaving 6,400 shares worth $473K. The position accounts for 0.02% of the portfolio, ranked #467.

Boston Advisors first reported a position in EMN in Q2 2013 and has held it in 26 quarters since. The position peaked at $16M in Q2 2014. 623 funds tracked by Wall St. Rank hold EMN as of Q3 2019.

  • Boston Advisors held 6,400 shares of Eastman Chemical worth $473K as of Q3 2019.
  • Boston Advisors sold 550 Eastman Chemical shares in Q3 2019, an estimated $39.5K.
  • Eastman Chemical made up 0.02% of Boston Advisors's portfolio in Q3 2019, its #467 holding.
  • Boston Advisors first reported a position in Eastman Chemical in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Eastman Chemical position peaked at $16M in Q2 2014.
  • 623 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.